The 'no DAC' CJC-1295 (modified GRF 1-29) lacks the drug-affinity-complex, giving a shorter-acting GHRH profile than DAC versions
Development 142 , 620632 (2015)
It is a melanocortin receptor agonist with systemic effects that include nausea, appetite suppression, and sexual side effects in 2030% of subjects at standard doses
Fowkes MM, Lalonde T, Yu L, Dhanvantari S, Kovacs MS, Luyt LG
These findings are fundamental in guiding treatment selections based on individual patient needs and therapeutic goals
Metabolic and Lipolytic Signaling Pathways Beyond anabolic signaling, IGF-1 LR3s receptor activation is linked to metabolic effects documented in research settings, including increased glucose uptake into muscle and adipose tissue via GLUT-4 transporter upregulation and enhanced amino acid transport that supports tissue repair processes